1. Personalized medicine, however you define it, is still in the very early stages. We have decades to go, probably on both the genetic and phenotypic fronts, before we can comfortably replace guidelines.
Saturday, July 27, 2013
Obamacare
and Accountability: Accountable to Whom?
Accountable
1. Subject to obligation to report, explain, or justify something, responsible,
answerable. 2. Capable of being explained.
Definition
of accountable
If you’ve kept abreast of the health policy
literature, you will have roften un across the word “accountable, ” as in accountable care organizations or accountable prescribing.
If so, you may have asked yourself, as I have, “Accountable
to whom?”
To government payers?
To health plans?
To the Accountable Care Organizations?
To adherence
to protocols, algorithms, guidelines?
To commitment to responsible, evidence-based
practice?
To the safest, most effective, and lowest costs for
your patient?
So the questions go.
Where the questions stop, no one knows.
But according to Joseph Kvedar, MD, Director of Connected Health at
Partners Health, the ultimate answer may reside in “Guidelines Vs Personalized
Health; the Battle for the Future of Healthcare” (The Health Care Blog, July 25, 2013)
Who and what will prevail? Guidelines from above
with algorithm-driven care? Clinical
judgment-driven care? Personalized health? A combination of
each? Decision-making by non-physician clinicians? The ultimate decision rendered by clinician
clinical judgment and instinct based on personalized decisions for personalized
patients?
Will decisions be based on evidence from
meta-studies of populations? Will these studies be reduced to guidelines? Will care be standardized and improved by
reducing variability? What if guidelines – based on large-scale, randomized
coordinated studies – don’t work for individual patients? Which kind of care
will be cheaper, safer, and more effective?
What about personalized medicine? What about
tailoring medical treatment to the individual characteristics of each
patient? What about physiological
monitoring of each patient, their mood,
their motivation, their activities, their genetics?
Here is Dr. Kvedar’s take on the matter.
1. Personalized medicine, however you define it, is still in the very early stages. We have decades to go, probably on both the genetic and phenotypic fronts, before we can comfortably replace guidelines.
1. Personalized medicine, however you define it, is still in the very early stages. We have decades to go, probably on both the genetic and phenotypic fronts, before we can comfortably replace guidelines.
2. We should welcome the sharing of decision-making across
the care team and maximize the use of non-physician clinicians. Guidelines
give us the state-of-the-art way to do this.
3. The best form of personalized medicine today is still
clinician instinct and judgment. This does not mean deferring all
clinical decisions to the most senior or most highly trained person on the
team. The care delivery culture can be modified to maximize
appropriate personalization of care while adhering appropriately to
guidelines. This requires an open culture where inquiry is encouraged.
Each care team member must be comfortable with what he or she doesn’t
know, with spotting exceptions to norms and engaging other team members in
a learning dialogue around these exceptions.
Personalized care has as much to do
with each patients, each physicians, and the culture in general as management
by accountability. Guidelines are based on populations when in reality individual
patients are all different and respond differently to the same treatment. The folks at the Dartmouth Institute of
Health Policy and Clinical Practice seem to think that accountable care, more
precisely accountable prescribing, is
more effective and more affordable than individual clinicians opinions and
actions (Nancy Morden, MD, et al, “Accountable Prescribing” New England Journal
of Medicine, July 25, 2013). Perhaps
time will tell where the best quality medicine lies.
How many times the word “accountable”
appears in Obamacare
literature is uncountable.
The fundamental idea is simply this:
If only variation we could dismiss,
and have all decisions based on scientific“evidence,”
garnered from studies of population prevalence,
Individual variation would decline,
effectiveness, proper use, and safety would incline.
The word in the ACA is “affordable,”
Translated means “accountable.”
If only this were so,
individual and personalized judgment
might be no mo,
Tweet: Obamacare
demands clinical “accountability,” a term sometimes at odds with individual judgment
and personalized care.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment